Pharmacopsychiatry 2010; 43(1): 37-38
DOI: 10.1055/s-0029-1239591
Letter

© Georg Thieme Verlag KG Stuttgart · New York

Mania Associated with Mirtazepine Treatment and Mixed Depression

B. Habermeyer1 , U. Bayer1 , F. Müller-Spahn1 , 2
  • 1Department of Psychiatry, University of Basel, Basel, Switzerland
  • 2Unfortunately Prof. Franz Müller-Spahn died before the review process was finished
Further Information

Publication History

16.02.2009

31.08.2009 31.08.2009

Publication Date:
10 December 2009 (online)

Mixed depressive states are a challenge for practitioners because reinforcement of antidepressant treatment might cause a switch to mania. We report the case of a mirtazepine-associated switch to mania in a patient presenting with mixed depressive symptoms. Currently only one mirtazepine-associated case of a switch to mania in mixed depression has bee reported. In contrast to that case, our patient was previously not treated with an SSRI before the medication was changed to mirtazepine. This makes complex pharmacological interactions in our case unlikely and highlights the relevance of the factor mixed depression. Although currently the concept of mixed states is not fully acknowledged in the diagnostic manuals, it should be recognized in order to choose the appropriate treatment options for patients at risk to develop manic symptoms.

References

  • 1 Bhanji NH, Margolese HC, Saint-Laurent M. et al . Dysphoric mania induced by high-dose mirtazapine: a case for ‘norepinephrine syndrome'?.  Int Clin Psychopharmacol. 2002;  17 319-322
  • 2 De Leon OA, Furmaga KM, Kaltsounis J. Mirtazapine-induced mania in a case of poststroke depression.  J Neuropsychiatry Clin Neurosci. 1999;  11 115-116
  • 3 Frye MA, Helleman G, McElroy SL. et al . Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.  Am J Psychiatry. 2009;  166 164-172
  • 4 Hamilton M. A rating scale for depression.  J Neurol Neurosurg Psychiatry. 1960;  23 56-62
  • 5 Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh: E & S Livingstone 1921
  • 6 Liu CC, Liang KY, Liao SC. Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features.  J Psychopharmacol. 2008;  23 220-222
  • 7 Montgomery SA. Safety of mirtazapine: a review.  Int Clin Psychopharmacol. 1995;  10 ((Suppl 4)) 37-45
  • 8 Ng B. Mania associated with mirtazapine augmentation of fluoxetine.  Depress Anxiety. 2002;  15 46-47
  • 9 Schneck CD. Mixed depression: the importance of rediscovering subtypes of mixed mood States.  Am J Psychiatry. 2009;  166 127-130
  • 10 Soutullo CA, McElroy SL, Keck PE. Hypomania associated with mirtazapine augmentation of sertraline.  J Clin Psychiatry. 1998;  59 320
  • 11 Stahl S. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 2nd edn New York: Cambridge University Press 2000
  • 12 Yatham LN, Kennedy SH, O'Donovan C. et al . Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.  Bipolar Disord. 2005;  7 ((Suppl 3)) 5-69
  • 13 Young RC, Biggs JT, Ziegler VE. et al . A rating scale for mania: reliability, validity and sensitivity.  Br J Psychiatry. 1978;  133 429-435

Correspondence

B. HabermeyerMD 

Department of Psychiatry

University of Basel

Wilhelm Klein-Straße 27

4056 Basel

Switzerland

Phone: +41/(0)61/325 5402

Fax: +41/(0)61/325 5405

Email: benedikt.habermeyer@upkbs.ch